COCRYSTAL PHARMA, INC. (COCP) Free cash flow 2016–2025
COCRYSTAL PHARMA, INC. (COCP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$8.2MFY2025 · since FY2016: -$14.7M → -$8.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.2M | +50.3% |
| FY2024 | -$16.5M | -11.6% |
| FY2023 | -$14.8M | +31.3% |
| FY2022 | -$21.5M | -68.4% |
| FY2021 | -$12.8M | -26.8% |
| FY2020 | -$10.1M | -489.6% |
| FY2019 | -$1.7M | +79.5% |
| FY2018 | -$8.3M | -19.8% |
| FY2017 | -$6.9M | +52.8% |
| FY2016 | -$14.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More COCP financial trends
COCP RevenueCOCP Net incomeCOCP Net marginCOCP Gross profitCOCP Gross marginCOCP Operating incomeCOCP Operating marginCOCP Operating cash flowCOCP Capital expendituresCOCP Return on equityCOCP Stock buybacksCOCP Dividends paidCOCP Total assetsCOCP Total liabilitiesCOCP Shareholders’ equityCOCP overview →